ArticleHarm reduction journal2006
Therapeutic challenges in hepatitis C-infected injection drug using patients.
Article in Harm reduction journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 18 citations in OpenAlex.
- Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2013Trial
- Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City.Harm reduction journal · 2021Article
- Substance use and hepatitis C: an ecological momentary assessment study.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2014Article
- Substance Use Related Stigma: What we Know and the Way Forward.Journal of addictive behaviors, therapy & rehabilitation · 2013Article
- Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision.Therapeutics and clinical risk management · 2010Article
- Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study.Pakistan journal of medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis C Viral (HCV) infection in the injection drug user (IDU) population is a major medical concern. Concurrent substance abuse, co-morbid mental health conditions, poor socioeconomic status and a complex treatment protocol that is often incompatible with the life styles of IDUs combine to account for poor uptake and completion of HCV treatment. This article discusses HCV antiviral treatment issues relevant to IDUs chronically infected with this virus. The effect of non-injected substances of abuse on treatment outcome is considered. Priority issues requiring research are discussed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.